Zusammenfassung
Die Hypertonie ist ein Hauptrisikofaktor für zerebrovaskuläre Erkrankungen, und zu den wesentlichen Vorteilen der modernen antihypertensiven Behandlung gehört die Prävention des Schlaganfalls. Die Hypertonie verursacht eine ausgeprägte strukturelle und funktionelle Adaptation der zerebralen Widerstandsgefäße. Gelegentlich können diese Veränderungen zur Entwicklung einer zerebralen Ischämie beitragen, wenn der Blutdruck unbeabsichtigt zu massiv gesenkt wird. In dem vorliegenden Beitrag wird erörtert, wie sich die Hypertonie und ihre Behandlung auf die zerebralen Gefäße und den Gehirnkreislauf auswirken.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Mazziotta JC, Phelps ME (1984) Human sensory Stimulation and deprivation: positron emission tomographic results and strategies. Ann Neurol [Suppl] 15: S50 - S60
Fencl V, Vale JR, Broch JA (1969) Respiration and cerebral blood flow in metabolic acidosis and alkalosis in humans. J Appl Physiol 27: 67–76
Paulson OB, Newman EA (1987) Does the release of potassium from astrocyte endfeet regulate cerebral blood flow. Science 237: 896–898
Winn HR, Welsh JE, Rubio R, Berne RM (1980) Brain adenosine production in rat during sustained alteration in systemic blood pressure. Am J Physiol (Heart Circ Physiol 8 ) 239: H636 - H41
Lassen NA (1959) Cerebral blood flow and oxygen consumption in man. Physiol Rev 39: 183– 238
Heistad DD, Kontos HA (1983) Cerebral circulation. In: Shepherd JT, Abbourd FM (eds) The cardiovascular system. American Physiological Society, Bethesda (Handbook of physiology, vol 3, sect 2, pp 137–182 )
Häggendal E, Johanson B (1965) Effects of arterial carbon dioxide tension and oxygen Saturation on cerebral blood flow autoregulation in dogs. Acta Physiol Scand [Suppl 258] 66: 27–53
MacKenzie ET, McGeorge AP, Graham DI, Fitch W, Edvinsson L, Harper AM (1979) Effects of increasing arterial pressure on cerebral blood flow in the baboon: influence of the sympathetic nervous system. Pfluegers Arch 378: 189–195
Hamar J, Kovch ABG, Reivich M, Nyry I, Durity F (1979) Effect of phenoxybenzamine on cerebral blood flow and metalolism in the baboon during haemorrhagic shock. Stroke 10: 401–407
Beausaug-Linder M, Bill A (1981) Cerebral circulation in acute arterial hypertension — protective effects of sympathetic nervous activity. Acta Physiol Scand III: 193–199
Edvinson L (1987) Neurogenic control of cerebral circulation. In: Hartman A, Kuschinsky W (eds) Cerebral ischemia and hemorheologi. Springer, Berlin Heidelberg New York Tokyo, pp 13–23
Barry DI, Jarden JO, Paulson OB, Graham DI, Strandgaard S (1984) Cerebrovascular effects of Converting enzyme Inhibition. I: Effects of intravenous Captopril in spontaneously hypertensive and normotensive rats. J Hypertens 2: 589–597
Paulson OB, Parving H–H, Olesen J, Skinh0j E (1973) Influence of carbon monoxide and of hemodilution on cerebral blood flow and blood gases in man. J Appl Physiol 35: 111–116
Kety SS, Hafkenschiel JH, Jeffers WA, Leopold IH, Shenkin HA (1948) The blood flow, vascular resistance, and oxygen consumption of the brain in essential hypertension. J Clin Invest 27: 511–514
Hart MN, Heistad DD, Brody MJ (1980) Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 2: 419–423
Gottstein U (1965) Physiologie und Pathophysiologie des Hirnkreislaufs. Med Welt 715–726
Strandgaard S, Olesen J, Skinhoj E, Lassen NA (1973) Autoregulation of brain circulation in severe arterial hypertension. Med J 1: 507–510
Strandgaard S (1976) Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 53: 720–727
Jonnes JV, Fitch W, MacKenzie ET, Strandgaard S, Harper AM (1976) Lower limit of cerebral blood flow autoregulation in the baboon. Circ Res 39: 555–557
Fujishima M, Omae T (1976) Lower limit of cerebral autoregulation in normotensive and spontaneously hypertensive rats. Experientia 32: 1019–1021
Barry DI, Strandgaard S, Graham DI et al. (1982) Cerebral blood flow in rats with renal and spontaneous hypertension: resetting of the lower limit of autoregulation. J Cereb Blood Flow Metab 2: 347–353
Brott T, Thalinger K, Hertzberg V (1986) Hypertension as a risk facfor for spontaneous intracerebral hemorrhage. Stroke 17: 1078–1083
Schulte BP, Leyten AC, Herman B (1985) Pre-stroke and immediate post-stroke hypertension: neuroepidemiological data. Br J Clin Pract [Symp Suppl] 39: 31–33
Roberts WC (1987) Frequency of systemic hypertension in various cardiovascular diseases. Am J Cardiol 60: 1E - 8E
Britton M, Carlsson A, de Faire U (1986) Blood pressure course in patients with acute stroke and matched controls. Stroke 17: 861–864
Fisher CM (1969) The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 12: 1–15
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1967) Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202: 1028–1034
Veterans Administration Cooperative Study Group on Anrihypertensive Agents (1970) Effects of treatment on morbidity in hypertension. II: Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213: 1143–1152
Management Committee of the Australian Hypertension Trial (1980) The Australian therapeutic trial in mild hypertension. Lancet 1: 1261–1267
Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. Br Med J 291: 97–104
Russell RWR (1975) How does blood-pressure cause stroke? Lancet II: 1283–1285
Russell RW (1984) Pathological changes in small cerebral arteries causing occlusion and haemorrhage. J Cardiovasc Pharmacol 6: S691–S695
Spence JD (1986) Antihypertensive drugs and prevention of atherosclerotic stroke. Stroke 17: 808–810
Sacco RL, Wolf PA, Bharucha NE et al. (1984) Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology 34: 847–854
Bonita R (1986) Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke 17: 831–835
Lassen NA, Agnoli A (1973) The Upper limit of autoregulation of cerebral blood flow — on the pathogenesis of hypertensive encephalopathy. Scand J Clin Lab Invest 30: 113–116
Strandgaard S (1978) Autoregulation of cerebral circulation in hypertension. Acta Neurol Scand [Suppl 66] 57: 1–82
Graham DI (1975) Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension. Br Med J 4: 739
Cove BH, Seddom M, Fletcher RF, Dukes DC (1979) Blindness after treatment for malignant hypertension. Br Med J 11: 245–246
Ledingham JGG, Rajagopalan B (1979) Cerebral complications in the treatment of accelerated hypertension. Q J Med 48: 25–41
Hülse JA, Taylor DSI, Dillon MJ (1979) Blindness and paraplegia in severe childhood hypertension. Lancet 11: 553–556
Strandgaard S, Andersen GS, Ahlgreen P, Nielsen PE (1984) Visual disturbances anc occipital brain infarct following acute, transient hypotension and hypertensive patients. Acta Med Scand 216: 417–422
Jackson G, Pierscianowski TA, Mahon W, Condon J (1976) Inappropriate antihypertensive therapy in the elderly. Lancet II: 1317–1318
Jansen PAF, Gribnau FWJ, Schultz BPM, Poels EFJ (1986) Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly. Br Med J 293: 914–917
Ruff RL, Talman WT, Petito F (1981) Transient ischemic attacks associated with hypotension in hypertensive patients with carotid artery stenosis. Stroke 12: 353–355
Spence JD, del Maestro RF (1985) Hypertension in acute ischemic stroke. Treat. Arch Neurol 42: 1000–1002
Yatsu FM, Zivin J (1985) Hypertension in acute ischemic strokes. Not to treat. Arch Neurol 42: 999–1000
Lavin P (1986) Management of hypertension in patients with acute stroke. Arch Intern Med 146: 66–68
Bannan LT, Beevers DG, Jackson SD, Wright N (1980) ABC of blood pressure reduction. Special problems. Br Med J 281: 1200–1202
American Heart Association (1973) Report of the Joint Committee for Stroke Facilities. VII. Medical and surgical management of stroke. Stroke 4: 270–309
Barry I, Strandgaard S, Graham DI, Brasndstrup O, Svendsen UG, Bolwig TG (1983) Effect of diaxozide induced hypotension on cerebral blood flow in hypertensive rats. Eur J Clin Invest 13: 201–207
Barry DI, Strandgaard S (1985) Acute effects of antihypertensive drugs on autoregulation of cerebral blood flow in spontaneously hypertensive rats. Prog Appl Microcirc 8: 206–212
Goldberg HI, Codario RA, Banka RS, Reivich M (1977) Patterns of cerebral disautoregulation in severe hypertension to blood pressure reduction with diazoxide. Acta Neurol Scand [Suppl 64] 56: 64–65
Vidt DG (1986) Current concept in treatment of hypertension emergencies. Am Heart J 111: 220–225
Rowe GG, Maxwell GM, Crumpton CW (1962) The cerebral haemodynamic response to administration of hydralazine. Circulation 25: 970–972
Overgaard J, Skinh0j E (1975) A paradoxical cerebral haemodynamid effect of hydralazine. Stroke 6: 402–404
Johansson BB, Auer LM, Trümmer UG (1980) Pial vascular reaction to intravenous dihydralazine in the cat. Stroke 11: 369–371
Barry DI, Strandgaard S, Graham DI, Svendsen UG, Brasndstrup O, Paulson OB (1984) Cerebral blood flow response to intravenous dihydralazine in renal and spontaneously hypertensive rats. Stroke 15: 102–107
Henriksen L, Thorshauge C, Harmsen A et al. (1983) Controlled hypotension with sodium nitroprusside: Effects of cerebral blood flow and cerebral venous blood gases in patients operated for cerebral aneurysms. Acta Anaesthesiol Scand 27: 62–67
Turner JM, Powell D, Gibson RM, McDowall DG (1977) Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitro prusside or trimetaphan. Br J Anaesthesiol 49: 419–420
Keaney NP, McDowall DG, Turner JM et al. (1975) Cerebral blood flow autoregulation cerebrospinal fluid acid–base parameters and profound hypotension induced by sodium nitroprusside and deep halothane anaesthesia. In: Langfitt TW, McHenry LC, Reivich M, Wollman H (eds) Cerebral circulation and metabolism. Springer, Berlin Heidelberg New York, pp 21–23
Fitch W, Pickard JD, Tamura A, Graham DI (1988) Effects of hypotension induced with sodium nitroprusside on the cerebral circulation before, and one week after, the subarachnoid injection of blood. J Neurol Neurosurg Psychiatry 51: 88–93
Henriksen L, Paulson OB (1982) The effects of sodium nitroprusside on cerebral blood flow and cerebral venous blood gases. II. Observations in awake man during successive blood pressure reduction. Eur J Clin Invest 12: 389–393
Bertel O, Conen D, Radii EW, Mueller J, Lang C, Dubach U (1983) Nifedepine in hypertensive emergencies. Br Med J 1: 19–21
Mohamed AA, McCulloch J, Mendelow AD, Teasdale GM, Harper AM (1984) Effect of the calcium antagonist nimodipine on local cerebral blood flow: Relationship to arterial blood pressure. J Cereb Blood Flow Metab 4: 206–211
Vorstrup S, Andersen A, Blegvad N, Paulson OB (1986) Calcium antagonist (PY 108–068) treatment may further decrease flow in ischemic areas in acute stroke. J Cereb Blood Flow Metabol 6: 222–229
Harris RJ, Branston NM, Symon L, Bayhan M, Watson A (1982) The effects of a calcium antagonist/nimodipine/ upon physiological responses of the cerebral vasculatur and its possible influence upon focal cerebral ischemia. Stroke 13: 759–760
Gaab MR, Höllerhage HG, Zumkeller M, Trost HA (1987) The effect of the Ca-antagonist nimodipine on cerebral blood flow autoregulation. J Cereb Blood Flow Metab [Suppl 1] 7: S170
Kerckhoff W van den, Kazda S (1987) The autoregulation of cerebral blood flow is influenced by calcium antagonists. J Cereb Blood Flow Metab [Suppl 1] 7: S169
Kincaid–Smith P, McMichael J, Murphy EA (1958) The clinical course and pathology of hypertension with papillo edema (malignant hypertension). Q J Med (New Series) 27: 117–153
Fitch W, MacKenzie ET, Harper AM (1975) Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Circ Res 37: 550–557
Waldemar G, Schmidt JF, Andersen AR, Vorstrup S, Ibsen H, Paulson OB (1989) Angiotensin Converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man. J Hypertens 7: 229–235
Paulson OB, Jarden JO, Vorstrup S, Holm S, Godtfredsen J (1986) Effect of Captopril on the cerebral circulation in chronic heart failure. Eur J Clin Invest 16: 124–132
Pedersen EV, Bobkiewicz-Kozlowska T, Waldemar G, Barry DI (1987) The renin angiotensin of cerebral arteries contributes to cerebrovascular resistance. Eur J Clin Invest 17: A38
Waldemar G, Paulson OB, Barry DI, Knudsen GM (1989) Angiotensin Converting enzyme inhibition and the Upper limit of cerebral blood flow autoregulation: Effect of sympathetic Stimulation. Circ Res 64: 1197–1204
Waldemar G (1990) Acute sympathetic denervation does not eliminate the effect of angiotensin Converting enzyme inhibition on CBF autoregulaton in spontaneously hypertensive rats. J Cereb Blood Flow Metab 10: 43–47
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Paulson, O.B., Strandgaard, S. (1991). Zerebraler Kreislauf bei Hypertonie: Risiken und therapeutische Bedeutung. In: Schmieder, R.E., Müller, HM., Messerli, F.H. (eds) Endorganschädigungen der arteriellen Hypertonie — Konsequenzen für Diagnostik und Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76361-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-76361-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53581-2
Online ISBN: 978-3-642-76361-8
eBook Packages: Springer Book Archive